Answers are grounded in this paper and cite their sources.
PURPOSE: To report a newly recognised advert event of clarithromycin. METHODS: Retrospective, case report. RESULTS: A 30-year old female referred to our centre with bilateral diffuse iris atrophy after the use of oral clarithromycin for a pulmonary infection. CONCLUSIONS: Bilateral acute depigmentation of the iris is a new clinical entity. Iris transillumination and sphincter paralysis are recognised adverse effects of oral antibiotic therapy, but to our knowledge no other publication has referred to uveitis-like syndrome due to oral administration of clarithromycin.
No takes yet. Share an insight, caveat, or question.
Tranos et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: